[
  {
    "objectID": "posts.html",
    "href": "posts.html",
    "title": "My Blog",
    "section": "",
    "text": "The biological-relevant questions\n\n\n\nMiscellany\n\n\n\nThe routine questions I donâ€™t know and the answers\n\n\n\nKang Wu\n\n\nSep 19, 2025\n\n\n\n\n\n\n\n\n\n\n\n\n\nSome good sentences\n\n\n\nsentences\n\n\n\nJust my point of view\n\n\n\nKang Wu\n\n\nSep 19, 2025\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "posts/maybe_good_sentences/index.html",
    "href": "posts/maybe_good_sentences/index.html",
    "title": "Some good sentences",
    "section": "",
    "text": "Antibody function is governed not only by antigen specificity, conferred by the antigen-binding (Fab) domain to neutralize pathogens but also by the antibody constant (Fc) domain, which recruits complement and engages Fc receptors (FcRs) on the surface of immune cells.\n\nImmunity. 2025. PMID: 40449485\n\nAny given MHC molecule can bind numerous different peptides, and some peptide can bind to several different MHC molecules. Because of this broad specificity, the binding between a peptide and an MHC molecule is often referred to as â€œpromiscuousâ€.\n\nKuby immunology 2018 p533\n\nâ€¦studies use a cross-validation approach, in which one chunk of a data set is reserved for training and another for testing. This can lead to issues such as overfitting, meaning that an algorithm performs well on data similar to the information that the model has encountered before but does poorly on disparate data. â€œThe problem with cross-validation is that it tends to provide fairly optimistic results,â€ Madabhushi explains. â€œThe cleanest and best way to validate these models is through external, independent validation, where the external test set is separate and distinct from the training set and ideally from a separate institution.â€\n\nNature. 2025. PMID: 40410341\n\nTrained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.\n\neLife. 2025. doi: 10.7554/eLife.107787\n\nWhether itâ€™s a sales skill, writing skill, musical talent, preaching ability, inventiveness, food production, cleaning, or childcare, these are all value-creation skills. Few people possess all these skills, and no one is the worldâ€™s best at all of them. Thatâ€™s why most people specialize and outsource the rest.\n\nIsrael Kloss on LinkedIn\n\nActually you have 22 pairs of chromosomes numbered 1 through 22, and if youâ€™re a woman, you have a pair of X chromosomes, for a total of 23 pairs. If youâ€™re a man, you have one X and one Y chromosome instead of two Xâ€™s, so the 23rd â€œpairâ€ isnâ€™t technically a pair at all, even though some parts of Y are identical to some parts of X.\n\nSteven Salzberg on Substack\n\nIt is important to be aware that most common image/photo editing software applications donâ€™t care about preserving pixel values. Only the appearance really matters. Therefore if you adjust the brightness/contrast of an image in such software you can easily make the image unsuitable for later quantitative analysis by compromising the data.\n\n\nIn practice, magnification is then not terribly meaningful: the pixel size is the crucial value needed to make measurements in physical units, and to compare the resolution across images.\n\nQuPath\n\nWriting compels us to think â€” not in the chaotic, non-linear way our minds typically wander, but in a structured, intentional manner.\n\nNature Reviews Bioengineering\n\nIn QuPath, as in life, it is neither easy nor wise to rewrite history.\n\nQuPath\n\nI am a strong believer that depth of data can be just as powerful as scale of data. Deep analysis of small groups of humans, and even individuals, can lead to novel biological insights and principles.\n\nAnsu Satpathy on X\n\nEnergy and initiative matter more than talent.\n\nMing Tommy Tang on BlueSky"
  },
  {
    "objectID": "posts/maybe_good_sentences/index.html#section",
    "href": "posts/maybe_good_sentences/index.html#section",
    "title": "Some good sentences",
    "section": "",
    "text": "Antibody function is governed not only by antigen specificity, conferred by the antigen-binding (Fab) domain to neutralize pathogens but also by the antibody constant (Fc) domain, which recruits complement and engages Fc receptors (FcRs) on the surface of immune cells.\n\nImmunity. 2025. PMID: 40449485\n\nAny given MHC molecule can bind numerous different peptides, and some peptide can bind to several different MHC molecules. Because of this broad specificity, the binding between a peptide and an MHC molecule is often referred to as â€œpromiscuousâ€.\n\nKuby immunology 2018 p533\n\nâ€¦studies use a cross-validation approach, in which one chunk of a data set is reserved for training and another for testing. This can lead to issues such as overfitting, meaning that an algorithm performs well on data similar to the information that the model has encountered before but does poorly on disparate data. â€œThe problem with cross-validation is that it tends to provide fairly optimistic results,â€ Madabhushi explains. â€œThe cleanest and best way to validate these models is through external, independent validation, where the external test set is separate and distinct from the training set and ideally from a separate institution.â€\n\nNature. 2025. PMID: 40410341\n\nTrained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.\n\neLife. 2025. doi: 10.7554/eLife.107787\n\nWhether itâ€™s a sales skill, writing skill, musical talent, preaching ability, inventiveness, food production, cleaning, or childcare, these are all value-creation skills. Few people possess all these skills, and no one is the worldâ€™s best at all of them. Thatâ€™s why most people specialize and outsource the rest.\n\nIsrael Kloss on LinkedIn\n\nActually you have 22 pairs of chromosomes numbered 1 through 22, and if youâ€™re a woman, you have a pair of X chromosomes, for a total of 23 pairs. If youâ€™re a man, you have one X and one Y chromosome instead of two Xâ€™s, so the 23rd â€œpairâ€ isnâ€™t technically a pair at all, even though some parts of Y are identical to some parts of X.\n\nSteven Salzberg on Substack\n\nIt is important to be aware that most common image/photo editing software applications donâ€™t care about preserving pixel values. Only the appearance really matters. Therefore if you adjust the brightness/contrast of an image in such software you can easily make the image unsuitable for later quantitative analysis by compromising the data.\n\n\nIn practice, magnification is then not terribly meaningful: the pixel size is the crucial value needed to make measurements in physical units, and to compare the resolution across images.\n\nQuPath\n\nWriting compels us to think â€” not in the chaotic, non-linear way our minds typically wander, but in a structured, intentional manner.\n\nNature Reviews Bioengineering\n\nIn QuPath, as in life, it is neither easy nor wise to rewrite history.\n\nQuPath\n\nI am a strong believer that depth of data can be just as powerful as scale of data. Deep analysis of small groups of humans, and even individuals, can lead to novel biological insights and principles.\n\nAnsu Satpathy on X\n\nEnergy and initiative matter more than talent.\n\nMing Tommy Tang on BlueSky"
  },
  {
    "objectID": "posts/maybe_good_sentences/index.html#section-1",
    "href": "posts/maybe_good_sentences/index.html#section-1",
    "title": "Some good sentences",
    "section": "2025-08",
    "text": "2025-08\n\nQuanlity before quantity.\n\nMing Tommy Tang on BlueSky\n\nThe testis is known for its immune-privileged status, maintained by the bloodâ€“testis barrier, which prevents autoimmune reactions against spermatogenic cells.\n\nMed Sci (Basel). 2025. PMID: 40843751\n\nâ€¦ doesnâ€™t yet have the thick skin to shrug off the hostility.\n\nRoy Perlis on LinkedIn\n\nGood ideas come from having lots of experience. And experience comes from having lots of bad ideas.\n\nItai Yanai on BlueSky"
  },
  {
    "objectID": "posts/maybe_good_sentences/index.html#section-2",
    "href": "posts/maybe_good_sentences/index.html#section-2",
    "title": "Some good sentences",
    "section": "2025-09",
    "text": "2025-09\n\nthe rapid growth and accumulation of sequence data have outpaced efficient analysis capabilities.\n\nbioRxiv. 2025\n\nClear lines of logical argument, precise definitions, often can only be composed in writing. Paper and pencil (or the word processor) are extensions of our brains.\n\nWolfgang Huber on BlueSky\n\nâ€¦ image analysis may be faster, more reproducible, and more quantitative than visual assessment.\n\nQuPath"
  },
  {
    "objectID": "cv.html",
    "href": "cv.html",
    "title": "1. åŸºæœ¬ä¿¡æ¯/background",
    "section": "",
    "text": "1. åŸºæœ¬ä¿¡æ¯/background\nå§“åï¼šå´åº·\næœ€é«˜å­¦å†ï¼šåšå£«\næ°‘æ—ï¼šæ±‰\né‚®ç®±ï¼šwu__kang@126.com\nå©šå§»ï¼šå·²å©š\nORCIDï¼š0000-0002-9024-795X\nä¸ªäººç½‘é¡µï¼šhttps://iamhealthy.github.io/\n\n\n2. æ•™è‚²/education\n\n\n2007/09 â€“ 2012/07ï¼Œä¸Šæµ·äº¤é€šå¤§å­¦ï¼Œç”Ÿç‰©åŒ–å­¦ä¸åˆ†å­ç”Ÿç‰©å­¦(åšå£«)\n\n\n2001/09 â€“ 2007/07ï¼Œè¥¿åŒ—å†œæ—ç§‘æŠ€å¤§å­¦ï¼Œç”Ÿç‰©æŠ€æœ¯(æœ¬ç¡•è¿è¯»)\n\n\n\n\n3. å·¥ä½œ/experience\n\n3.4 2022/07 - è‡³ä»Šï¼Œä¸Šæµ·é”èµ›å¾ªç›Šç”Ÿç‰©æŠ€æœ¯æœ‰é™å…¬å¸ï¼Œç§‘åˆ›ä¸­å¿ƒ(é«˜çº§å¼€å‘æ€»ç›‘)\n\n\nè‚¿ç˜¤åˆ†å­è¯Šæ–­äº§å“å¼€å‘(ç›¸å…³ä¸“åˆ©ç”³è¯·å·ï¼š202410274764.3ã€202410372505.4)ã€‚\n\n\nåŸºäºNGSçš„è¯Šæ–­æŠ€æœ¯å’Œäº§å“å¼€å‘(ç›¸å…³ä¸“åˆ©æˆæƒå…¬å‘Šå·ï¼šCN117343999Bã€CN117701691B)ã€‚\n\n\nDCsç–«è‹—ä¸´åºŠè¯•éªŒå’Œåº”ç”¨æ”¯æŒã€é—´å……è´¨å¹²ç»†èƒå¤–æ³Œä½“ä¸´åºŠè¯•éªŒå’Œåº”ç”¨æ”¯æŒã€‚\n\n\nè‚¿ç˜¤panel NGSæ•°æ®çš„ç”Ÿä¿¡åˆ†æï¼Œå‘ç°åŸºå› /è›‹ç™½çªå˜ä»¥æŒ‡å¯¼ä¸´åºŠä¸ªä½“åŒ–ç”¨è¯ã€‚\n\n\nä¸´åºŠç›¸å…³æ•°æ®çš„ç”Ÿä¿¡åˆ†æå’Œæ”¯æŒã€‚\n\n\n\n\n3.3 2021/08 â€“ 2022/06ï¼Œæ­å·æ°æ¯…ç”Ÿç‰©æŠ€æœ¯æœ‰é™å…¬å¸ï¼Œåˆ›æ–°åº”ç”¨ç ”ç©¶é™¢(åŒ»å­¦ç§‘å­¦å®¶)\n\n\nåŸºäºå…¬å¸çš„mNGSäº§å“å’Œä¸´åºŠåŒ»ç”Ÿ/ç§‘å®¤å¼€å±•åˆä½œé¡¹ç›®ï¼Œå‚ä¸å¹¶æŒ‡å¯¼ç›¸å…³é¡¹ç›®ä¹¦æ’°å†™ã€é¡¹ç›®æ¨è¿›ã€é¡¹ç›®ç»“é¢˜(æ¯”å¦‚æ•°æ®æ•´ç†ã€åˆ†æï¼ŒSCIæ–‡ç« æ’°å†™)ã€‚\n\n\n\n\n3.2 2021/06 â€“ 2021/08ï¼Œä¸Šæµ·æ´¾æ£®è¯ºç”Ÿç‰©ç§‘æŠ€æœ‰é™å…¬å¸ï¼Œç ”å‘ä¸­å¿ƒ(ç ”å‘é¡¹ç›®ç»ç†)\n\n\nè´Ÿè´£åœ¨å…¬å¸å»ºç«‹metagenomic next-generation sequencing (mNGS)è¯Šæ–­æŠ€æœ¯ã€‚çŸ­æš‚çš„3ä¸ªæœˆå·¥ä½œæœŸé—´ï¼Œå¸¦é¢†3ä¸ªäººçš„å›¢é˜Ÿå»ºç«‹äº†è¯¥æŠ€æœ¯çš„å®éªŒéƒ¨åˆ†ï¼ŒåŠç”Ÿä¿¡åˆ†æçš„æ¡†æ¶ã€‚\n\n\n\n\n3.1 2012/07 â€“ 2021/06ï¼Œå¤æ—¦å¤§å­¦é™„å±ä¸Šæµ·å¸‚å…¬å…±å«ç”Ÿä¸´åºŠä¸­å¿ƒï¼Œç§‘å­¦ç ”ç©¶éƒ¨(åŠ©ç†ç ”ç©¶å‘˜)\n\n\nå®¿ä¸»(å¿—æ„¿è€…å¤–å‘¨è¡€ã€åå™¬ç»†èƒ)å¯¹äºç»“æ ¸åˆ†ææ†èŒçš„(å…¨åŸºå› ç»„)è½¬å½•åº”ç­”å’Œç”Ÿä¿¡åˆ†æ(ç›¸å…³ä¸“åˆ©æˆæƒå…¬å‘Šå·ï¼šCN104182654B)ã€‚\n\n\nç‰›åˆ†ææ†èŒå¡ä»‹è‹—(ç»“æ ¸ç–«è‹—)çš„åŸºå› é‡ç»„æ”¹é€ ï¼ŒåŠåœ¨å°é¼ çš„å…ç–«ä¿æŠ¤ç ”ç©¶(ç›¸å…³ä¸“åˆ©æˆæƒå…¬å‘Šå·ï¼šCN111979162Bã€CN106148258B)ã€‚\n\n\nç™½è¡€ç—…å‘ç—…æœºç†æ¢ç´¢(åˆ†å­å’Œç»†èƒå±‚é¢)(ç›¸å…³ä¸“åˆ©æˆæƒå…¬å‘Šå·ï¼šCN103740760B)ã€‚\n\n\n\n\n\n4. æœŸåˆŠè®ºæ–‡/journal articles\n\n4.1 (å¹¶åˆ—)ä¸€ä½œ/(co-)1st author SCI (# co-first authorï¼Œ*corresponding author)\n\n\nXu JC#, Wu K#, Ma RQ, Li JH, Tao J, Hu ZD, Fan XY*. Establishment of an in vitro model of monocyte-like THP-1 cells for trained immunity induced by bacillus Calmette-GuÃ©rin. BMC Microbiol. 2024;24:130. (IF: 4.2)\n\n\nShi JC#, Wu WJ#, Wu K#, Ni CR, He GQ, Zheng SL, Cheng F, Yi YX, Ren RT*, Jiang XG*. The diagnosis of leptospirosis complicated by pulmonary tuberculosis complemented by metagenomic next-generation sequencing: a case report. Front Cell Infect Microbiol. 2022;12:922996. (Case report). (IF: 5.7)\n\n\nLiu C#, Wu K#, Sun TY, Chen B, Yi YX, Ren RT*, Xie LX*, Xiao K*. Effect of invasive mechanical ventilation on the diversity of the pulmonary microbiota. Crit Care. 2022;26:252. (Review). (IF: 15.1)\n\n\nWu K, Yan B, Douglas BL, Li T*, Fan XY*. Tailored co-localization analysis of intracellular microbes and punctum-distributed phagosome-lysosome pathway proteins using ImageJ plugin EzColocalization. Sci Rep. 2021;11:1096. (IF: 4.996)\n\n\nWu K, Li M, Chen ZY, Douglas BL*, Fan XY*. Probe signal values in mRNA arrays imply an excessive involvement of neutrophil FCGR1 in tuberculosis. Front Med. 2020;7:19. (IF: 5.091)\n\n\nPei ZL#, Wu K#, Li ZH#, Li CQ#, Zeng L, Li F, Pei N, Liu HM, Zhang SL, Song YZ, Zhang XY, Xu JQ, Fan XY*, Wang J*. Pharmacologic ascorbate as a pro-drug for hydrogen peroxide release to kill mycobacteria. Biomed Pharmacother. 2019;109:2119-2127. (IF: 4.545)\n\n\nWu K#, Wong KW#, Deng WL, Zhang H, Li J, Lowrie DB*, Fan XY*. The numerical predominance and large transcriptome differences of neutrophils in peripheral blood together inevitably account for a reported pulmonary tuberculosis signature. Int J Genomics. 2017;2017:5830971. (IF: 1.904)\n\n\nWu K#, Zhao XJ#, Wong KW, Fan XY*. Comparison of plasmid DNA versus PCR amplified gene of insert DNA for nucleofection in Kasumi-1 cells. Cytotechnology. 2015;67(2):275-283. (IF: 1.864)\n\n\nWu K, Fang H, Lyu LD, Lowrie DB, Wong KW*, Fan XY*. A derived network-based interferon-related signature of human macrophages responding to Mycobacterium tuberculosis. Biomed Res Int. 2014;2014:713071. (IF: 1.579)\n\n\nMa H#, Wu K#, Liu F Yang H, Kang H, Chen NN, Yuan Q, Zhou WJ, Fan XY*. Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice. J Immunol Res. 2014;2014:196124. (IF: 2.934)\n\n\nJin W#, Wu K#, Li YZ# Yang WT, Zou B, Zhang F, Zhang J*, Wang KK*. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia. Oncogene. 2013;32(15):1978-1987. (IF: 8.559)\n\n\nWu K#, Dong DD#, Fang H#, Levillain F#, Jin W, Mei J, Gicquel B, Du Y, Wang K, Gao Q, Neyrolles O*, Zhang J*. An interferon-related signature in the transcriptional core response of human macrophages to Mycobacterium tuberculosis infection. PLoS One. 2012;7(6):e38367. (IF: 3.730)\n\n\näº¦å¯é€šè¿‡My Bibliography (NCBI)æŸ¥çœ‹å¦‚ä¸Šåˆ—è¡¨ï¼šhttps://www.ncbi.nlm.nih.gov/myncbi/1xKGynflhNK5t/bibliography/public/\n\n\n\n\n4.2 (å¹¶åˆ—)ä¸€ä½œä¸­æ–‡/(co-)1st author Chinese (# co-first authorï¼Œ*corresponding author)\n\n\nå´åº·#ã€å±ˆè“‰#ã€ç‹åˆšã€è–›æ¸…åã€å•å»ºæ–°ã€Douglas B. Lowrieã€èŒƒå°å‹‡*ã€‚åŸºäºå¸¸è§„å¼•ç‰©é¶å‘ç»“æ ¸åˆ†ææ†èŒIIå‹åˆ†ææ†èŒæ•£åœ¨é‡å¤å•ä½çš„æ’æ¸©æ‰©å¢ã€‚å¤æ—¦å­¦æŠ¥(åŒ»å­¦ç‰ˆ)ã€‚2020;47:799-808ã€‚\n\n\n\n\n4.3 ä¸€ä¸ªæœ‰æ„æ€çš„æ–‡ç¨¿/one interesting draft\n\n\nå´åº·ã€‚ã€Šçº¢æ¥¼æ¢¦ã€‹ä¸­çš„ç–‘ä¼¼æ´»åŠ¨æ€§ç»“æ ¸ç—…æ‚£è€…ã€‚çŸ¥ä¹ (https://zhuanlan.zhihu.com/p/148348007)ã€‚2020ã€‚\n\n\n\n\n4.4 é(å¹¶åˆ—)ä¸€ä½œæ–‡ç« /non-(co-)1st articles (# co-first authorï¼Œ*corresponding author)\n\n\nHuang Z#, Huang H#, Hu J, Xia L, Liu XH, Qu R, Huang XL, Yang Y, Wu K, Ma RQ, Xu JC, Chen ZY, Wu YH, Yang J, Fang Y, Zeng JF, Lai WH, Sui GD, Sha W, Xiong YH, Lu SH*, Fan XY*. A novel quantitative urine LAM strip for point-of-care tuberculosis diagnosis in non-HIV adults. J Infect. 2023;S0163-4453(23)00586-8. (Letter).\n\n\nHuang H#, Qu R#, Wu K, Xu JC, Li JH, Lu SH, Sui GD, Fan XY*. Proteinase K-pretreated ConA-based ELISA assay: a novel urine LAM detection strategy for TB diagnosis. Front Microbiol. 2023;14:1236599.\n\n\nå±ˆè“‰ã€å´åº·ã€å´å¨Ÿã€èŒƒå°å‹‡ã€å•å»ºæ–°*ã€‚ç»“æ ¸åˆ†ææ†èŒæ—©æœŸåˆ†æ³Œè›‹ç™½MPT64çš„åŸæ ¸è¡¨è¾¾åŠå…¶åœ¨ç»“æ ¸ç—…è¡€æ¸…å­¦è¯Šæ–­ä¸Šçš„åˆæ­¥åº”ç”¨ã€‚ä¸­å›½ç”Ÿç‰©åˆ¶å“å­¦æ‚å¿—ã€‚2021:34(05):566-570ã€‚\n\n\nZhao HM#, Du R#, Li CL, Ji P, Li HC, Wu K, Hu ZD, Lu SH, Douglas BL, Fan XY*. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection. J Infect. 2019;78(4):275-280.\n\n\nHu ZD#, Wong KW#, Zhao HM, Wen HL, Ji P, Ma H, Wu K, Lu SH, Li F, Li ZM, Shu T, Xu JQ, Douglas BL, Fan XY*. Sendai virus mucosal vaccination establishes lung-resident memory CD8 T cell immunity and boosts BCG-primed protection against TB in mice. Mol Ther. 2017;25(5):1222-1233.\n\n\nWen HL, Li CL, Li G, Lu YH, Li HC, Li T, Zhao HM, Wu K, Douglas BL, Lv JX, Lu SH*, Fan XY*. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-Î³ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations. Eur J Clin Microbiol Infect Dis. 2017;36(8):1415-1423.\n\n\nLi G#, Li F#, Zhao HM, Wen HL, Li HC, Li CL, Ji P, Xu P, Wu K, Hu ZD, Lu SH, Douglas BL, Lv JX*, Fan XY*. Evaluation of a new IFN-Î³ release assay for rapid diagnosis of active tuberculosis in a high-incidence setting. Front Cell Infect Microbiol. 2017;7:117.\n\n\nææ˜¥ç²ã€å´åº·ã€èŒƒå°å‹‡*ã€‚æ°§åŒ–åº”æ¿€ä¸ç»“æ ¸ç—…ã€‚ç”Ÿå‘½ç§‘å­¦ã€‚2017;29(11):1108-1112ã€‚(ç»¼è¿°)ã€‚\n\n\né—®å¯’åˆ©ã€ææµ·èªã€ææ ¹ã€èµµæ…§æ•ã€æ–½ç†æ•ã€éŸ©ä¼Ÿé–ã€å´åº·ã€èŒƒå°å‹‡*ã€‚ç»“æ ¸åˆ†ææ†èŒè‚ç´ ç»“åˆè¡€å‡é»é™„ç´ çš„åŸæ ¸è¡¨è¾¾åŠå…¶åœ¨ç»“æ ¸ç—…è¡€æ¸…å­¦è¯Šæ–­ä¸­çš„åº”ç”¨ã€‚ä¸­å›½ç”Ÿç‰©åˆ¶å“å­¦æ‚å¿—ã€‚2016;29(05):497-502ã€‚\n\n\nChen L, Guo S, Wu LX, Fan XY, Ma H, Wu K, Wu J, Zhang JH*. IL-17A Autoantibody Induced by Recombinant Mycobacterium smegmatis Expressing Ag85A-IL-17A Fusion Protein. Appl Biochem Biotechnol. 2015; 176(7):2018-2026.\n\n\nå‰èã€èŒƒå°å‹‡*ã€å´åº·ã€å¢æ°´åã€‚ç»“æ ¸åˆ†ææ†èŒæ½œä¼æ€§æ„ŸæŸ“ç›¸å…³æŠ—åŸçš„ç ”ç©¶è¿›å±•ã€‚ä¸­åå¾®ç”Ÿç‰©å­¦å’Œå…ç–«å­¦æ‚å¿—ã€‚2015;35(1):59-64ã€‚(ç»¼è¿°)ã€‚\n\n\nKang H, Yuan Q, Ma H, Hu ZD, Han DP, Wu K, Douglas BL, Fan XY*. Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination. Immunology. 2014;143(4):661-669.\n\n\n\n\n4.5 æ”¾å¼ƒå‘è¡¨çš„ä¸€ä½œæ–‡ç« /1st author articles abandoned for publication (# co-first authorï¼Œ*corresponding author)\n\n\nWu K, Douglas BL*, Fan XY*. Fever of unknown origin and incipient tuberculosis. Un-published. Drafted in 2020. (Letter).\n\n\nWu K, Douglas BL, Wong KW*, Fan XY*. Re-analysis of the transcriptome data of host Macrophages in response to Mycobacterium tuberculosis infection by weighted gene co-expression network analysis. Un-published. Drafted in 2014.\n\n\nè‹¥æ„Ÿå…´è¶£ï¼Œå¯åˆ†äº«ã€‚\n\n\n\n\n4.6 è¢«è‡´è°¢çš„æ–‡ç« /acknowledged articles(# co-first authorï¼Œ*corresponding author)\n\n\nCheng XB#, Chai RR#, Zhang T#, Chen YJ, Fan FQ, Ye YF, Jin GQ, Li TT, Wang H, Ding JW, Zheng M, Han YH, Tang QZ, Song ZQ, Ji YQ, Song WW, Luo WF*, Kang Y*. A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening. Sci Rep. 2024;14(1):25556. â€œIn particular, we acknowledge Dr.Â Wu Kang for giving professional advice on this article.â€\n\n\n\n\n\n5. ä¸“åˆ©/patents\n\n\nå¼ è…¾ã€å´åº·ã€çºªé€¸ç¾¤ã€ä¸œäºšå¨Ÿã€é’Ÿå†›ã€ç½—å«å³°ã€èŒƒå°å‹‡ã€èµµå»ºåã€‚ä¸€ç§æ”¹å˜ä¸åŒæ ¸é…¸é¶æ ‡ç›¸å¯¹PCRæ‰©å¢é€Ÿåº¦çš„æ–¹æ³•ã€‚å‘æ˜ä¸“åˆ©ã€‚ç”³è¯·å·ï¼š202410372505.4ã€‚ç”³è¯·æ—¥æœŸï¼š2024.03.29ã€‚è¯¥ä¸“åˆ©åœ¨2024.06.18è¢«é©³å›ã€‚æœ¬äººè‡ªè®¤ä¸ºè¯¥ä¸“åˆ©æœ‰æœ‰è¶£çš„å‘ç°ï¼Œå³é€šè¿‡å…·ä½“å®éªŒè¯å®äº†å¸¦æœ‰é€šç”¨å¼•ç‰©åºåˆ—çš„é¶æ ‡ç‰¹å¼‚å¼•ç‰©å¯¹çš„qPCRæ‰©å¢æ€§èƒ½æ›´å¥½ï¼ˆæ‰©å¢ä½“ç³»äº¦åŒ…æ‹¬é€šç”¨å¼•ç‰©å¯¹ã€‚ç›¸æ¯”äºæœªå¸¦é€šç”¨å¼•ç‰©åºåˆ—çš„é¶æ ‡ç‰¹å¼‚å¼•ç‰©å¯¹çš„qPCRï¼‰ï¼Œè¿›è€Œèƒ½å¤Ÿè¾ƒå¥½å®ç°æ”¹å˜ä¸åŒæ ¸é…¸é¶æ ‡çš„ç›¸å¯¹PCRæ‰©å¢é€Ÿåº¦çš„ç›®çš„ã€‚\n\n\nå´åº·ã€å¼ è…¾ã€çºªé€¸ç¾¤ã€é’Ÿå†›ã€ç½—å«å³°ã€èŒƒå°å‹‡ã€èµµå»ºåã€‚ä¸€ç§é€šè¿‡é¢„å…ˆPCRæ”¹å˜ä¸åŒæ ¸é…¸é¶æ ‡ç›¸å¯¹æ‰©å¢é€Ÿåº¦çš„æ–¹æ³•ã€‚å‘æ˜ä¸“åˆ©ã€‚ç”³è¯·å·ï¼š202410274764.3ã€‚ç”³è¯·æ—¥æœŸï¼š2024.03.11ã€‚\n\n\nå´åº·ã€èµµå»ºåã€å¼ è…¾ã€èŒƒå°å‹‡ã€ç½—å«å³°ã€ä¸œäºšå¨Ÿã€çºªé€¸ç¾¤ã€‚åŸºäºäººåŸºå› ç»„æ‰©å¢å­çš„ illumina æµ‹åºæ–‡åº“æ„å»ºçš„å¼•ç‰©ç»„åˆã€‚å‘æ˜ä¸“åˆ©ã€‚æˆæƒå…¬å‘Šå·ï¼šCN117701691Bã€‚ç”³è¯·æ—¥æœŸï¼š2024.02.01ã€‚\n\n\nå´åº·ã€ä¸œäºšå¨Ÿã€å¼ è…¾ã€èŒƒå°å‹‡ã€ç½—å«å³°ã€èµµå»ºåã€çºªé€¸ç¾¤ã€‚åŸºäºå·¦ä¾§æ¢é’ˆé€€ç«å’Œå³ä¾§æ¢é’ˆé€€ç«å»¶ä¼¸çš„æ ¸é…¸æ‰©å¢æ–¹æ³•ã€‚å‘æ˜ä¸“åˆ©ã€‚æˆæƒå…¬å‘Šå·ï¼šCN117343999Bã€‚ç”³è¯·æ—¥æœŸï¼š2023.12.05ã€‚\n\n\nèŒƒå°å‹‡ã€å´åº·ã€ç½—é“è‰¯ã€‚åŸºäºå¸¸è§„å¼•ç‰©çš„é’ˆå¯¹ä¸²è”é‡å¤åºåˆ—çš„æ’æ¸©æ‰©å¢ä½“ç³»ã€æ‰©å¢æ–¹æ³•åŠå¸¸è§„å¼•ç‰©å¯¹ã€‚å‘æ˜ä¸“åˆ©ã€‚æˆæƒå…¬å‘Šå·ï¼šCN111269969Bï¼›ç”³è¯·æ—¥æœŸï¼š2020.03.06ã€‚\n\n\nèŒƒå°å‹‡ã€å´åº·ã€ç½—é“è‰¯ã€‚é‡ç»„å¡ä»‹è‹—èŒæ ªã€å…¶åˆ¶å¤‡æ–¹æ³•å’Œç”¨é€”ã€‚å‘æ˜ä¸“åˆ©ã€‚æˆæƒå…¬å‘Šå·ï¼šCN111979162Bï¼›ç”³è¯·æ—¥æœŸï¼š2019.05.22ã€‚\n\n\nèŒƒå°å‹‡ã€å•äº®ä¸œã€èµµå›½å±ã€é©¬è¾‰ã€å´åº·ã€‚mazGåŸºå› ç¼ºå¤±çš„æŠ—ç»“æ ¸é‡ç»„å¡ä»‹è‹—ã€‚å‘æ˜ä¸“åˆ©ã€‚æˆæƒå…¬å‘Šå·ï¼šCN106148258Bï¼›ç”³è¯·æ—¥æœŸï¼š2015.04.20ã€‚\n\n\nå´åº·ã€é»„å®¶é¢–ã€èŒƒå°å‹‡ã€‚åŸºäºè›‹ç™½-è›‹ç™½ç›¸äº’ä½œç”¨ç½‘ç»œçš„åŸºå› é›†é‰´å®šæ–¹æ³•ã€‚å‘æ˜ä¸“åˆ©ã€‚æˆæƒå…¬å‘Šå·ï¼šCN104182654Bï¼›ç”³è¯·æ—¥æœŸï¼š2014.07.30ã€‚\n\n\nå´åº·ã€èŒƒå°å‹‡ã€é»„å®¶é¢–ã€èµµæ—­æ°ã€‚PCRæ‰©å¢åŸºå› æ ¸è½¬æ‚¬æµ®åŠ¨ç‰©ç»†èƒçš„æ–¹æ³•ã€‚å‘æ˜ä¸“åˆ©ã€‚æˆæƒå…¬å‘Šå·ï¼šCN103740760Bï¼›ç”³è¯·æ—¥æœŸï¼š2014.01.09ã€‚ä¸“åˆ©æƒç»ˆæ­¢æ—¥æœŸï¼š2024.01.09ã€‚\n\n\n\n\n6. ç§‘ç ”é¡¹ç›®/scientific projects\n\n\n\n\n\n\n\n\n\n\n\n\nåºå·\né¡¹ç›®ç±»å‹\né¡¹ç›®åç§°\né¡¹ç›®å·\nè´Ÿè´£äºº\næœŸé™\nç»è´¹é¢(ä¸‡)\n\n\n\n\n5\nèˆŸå±±å¸‚æ™®é™€åŒºä¸€èˆ¬ç§‘æŠ€è®¡åˆ’é¡¹ç›®\nåŸºäºé¶å‘é«˜é€šé‡æµ‹åºçš„è†€èƒ±ç™Œå’Œæ³Œå°¿æ„ŸæŸ“é›†æˆè¯Šæ–­çš„æŠ€æœ¯å’Œäº§å“ç ”å‘\n2023YB003\nå´åº·\n2023/01-2025/06\n20\n\n\n4\nä¸Šæµ·å¸‚ç§‘å§”åŒ»å­¦å¼•å¯¼\nç»“æ ¸åˆ†ææ†èŒDosRæŠ—åŸåœ¨ç»“æ ¸ç—…å…ç–«é‰´åˆ«è¯Šæ–­åŠä¸´åºŠé¢„åä¸­çš„åº”ç”¨ç ”ç©¶\n18411970700\nå´åº·\n2018/09-2021/09\n20\n\n\n3\nå›½å®¶é‡ç‚¹ç ”å‘è®¡åˆ’\nç§ç•œåœºç‰›ç»“æ ¸å’Œå¸ƒé²æ°èŒç—…ç»¼åˆé˜²æ§ä¸å‡€åŒ–æŠ€æœ¯é›†æˆä¸ç¤ºèŒƒâ€“&gt;è¯¾é¢˜2ï¼šç‰›ç»“æ ¸è¯Šæ–­æŠ€æœ¯é›†æˆä¸å‡€åŒ–ç¤ºèŒƒâ€“&gt;å­è¯¾é¢˜3ï¼šåŸºäºå¾®æµæ§èŠ¯ç‰‡çš„ç‰›ç»“æ ¸æŠ—åŸå¿«é€Ÿæ£€æµ‹äº§å“çš„ç ”å‘\n2018YFD0500900\nå´åº·(å­è¯¾é¢˜3)\n2018/06-2021/09\n47/1263\n\n\n2\nå›½è‡ªç„¶é’å¹´\nç»“æ ¸åˆ†ææ†èŒèƒå†…è¡¨è¾¾ä¸Šè°ƒåˆ†æ³Œæ€§åŸºå› é›†çš„Tç»†èƒæŠ—åŸç­›é€‰åŠå…¶å…ç–«ä¿æŠ¤åŠŸèƒ½é‰´å®š\n81301407\nå´åº·\n2014/01-2016/12\n23\n\n\n1\nä¸Šæµ·å¸‚ç§‘å§”é’å¹´\nActAä¿ƒè¿›åˆ†ææ†èŒè‡ªå™¬é€ƒé€¸å¹¶æé«˜å¡ä»‹è‹—MHC Iç±»æŠ—åŸå‘ˆé€’çš„ç ”ç©¶\n12ZR1448200\nå´åº·\n2012/10-2015/09\n10\n\n\n\n\n\n7. äººæ‰é¡¹ç›®/talent projects\n\n\n\n\n\n\n\n\n\n\n\nåºå·\né¡¹ç›®åç§°\né¡¹ç›®å·\nè´Ÿè´£äºº\næœŸé™\nç»è´¹é¢(ä¸‡)\n\n\n\n\n1\nèˆŸå±±å¸‚â€œèˆŸåˆ›æœªæ¥â€æµ·çº³è®¡åˆ’åˆ›æ–°é•¿æœŸäººæ‰ II ç±»\nã€2023ã€‘ç¬¬ 1 æ‰¹-08\nå´åº·\n2024/04-2029/04\n30"
  },
  {
    "objectID": "contact.html",
    "href": "contact.html",
    "title": "Contact",
    "section": "",
    "text": "Phone: +86-15821314790\nEmail_1: wu__kang@126.com\nEmail_2: wukangx9@gmail.com\nEmail_3: 15821314790@126.com\nWechat: +86-15821314790, or scan the following QR code:"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Kang Wu/å´åº·",
    "section": "",
    "text": "1ï¸âƒ£After my Ph.D.ğŸ‘¨ğŸ»â€ğŸ“in Shanghai Jiao Tong U., I became a Research Assistant at Shanghai Public Health Clinical Center (affiliated with Fudan U.), focusing on TB immunology, vaccine development, and bioinformatics (2012 - 2021).\n2ï¸âƒ£Then after transitioning to industry, I have continued to pursueğŸ•µğŸ»advancements in omics-, cell-, and BioImageAnalysis-relevant technologies, particularly in therapeutic and diagnostic applications.\n3ï¸âƒ£I am self-taught in R, and am continually enhancing Python, Bash, and PowerShell capabilitiesğŸš¶ğŸ»â€â¡ï¸."
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html",
    "title": "The biological-relevant questions",
    "section": "",
    "text": "A1: You can check out this website: International Committee on Taxonomy of Viruses: ICTV."
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html#q1-is-there-a-website-where-we-can-check-whether-a-virus-is-a-dna-or-rna-virus-and-beyond",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html#q1-is-there-a-website-where-we-can-check-whether-a-virus-is-a-dna-or-rna-virus-and-beyond",
    "title": "The biological-relevant questions",
    "section": "",
    "text": "A1: You can check out this website: International Committee on Taxonomy of Viruses: ICTV."
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html#q2-how-to-define-a-successful-pathogen",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html#q2-how-to-define-a-successful-pathogen",
    "title": "The biological-relevant questions",
    "section": "Q2: How to define a successful pathogen?",
    "text": "Q2: How to define a successful pathogen?\nA2:\n\nAlthough the definition of a successful pathogen can be uncertain and controversial, in recent years, this term has been used to define those microorganisms that manage to establish a successful relationship with their host, which guarantees its transmissibility and its permanence on Earth. Thus, the ability of a microorganism to rapidly adapt to changes in the microenvironment through the deployment of specialized strategies, and survive within its host despite the deadly attack of the innate and adaptive immune response seems to be the key leading to evolutionary success.\n\n\nC. glabrata (å…‰æ»‘å¿µç èŒï¼ŒçœŸèŒ) is a successful pathogen and an artist manipulating the immune response like M. tuberculosis (ç»“æ ¸åˆ†ææ†èŒï¼Œç»†èŒ).\n\nMicrobiol Res. 2022. PMID: 35430489\nThen, how to define a successful person?"
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html#q3-how-long-can-mycobacterium-tuberculosis-hold-its-breath",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html#q3-how-long-can-mycobacterium-tuberculosis-hold-its-breath",
    "title": "The biological-relevant questions",
    "section": "Q3: How long can Mycobacterium tuberculosis â€œhold its breathâ€?",
    "text": "Q3: How long can Mycobacterium tuberculosis â€œhold its breathâ€?\nA3:\n\nFor example, Corper and Cohn, showed that sealed Mtb cultures held at 37Â°C for 12-30 years yielded viable bacilli in their anaerobic sediments.\n\nAm J Respir Crit Care Med. 2022. PMID: 35442854"
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html#q4-how-long-ago-was-the-first-case-of-tuberculosis-tb-discovered",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html#q4-how-long-ago-was-the-first-case-of-tuberculosis-tb-discovered",
    "title": "The biological-relevant questions",
    "section": "Q4: How long ago was the first case of tuberculosis (TB) discovered?",
    "text": "Q4: How long ago was the first case of tuberculosis (TB) discovered?\nA4:\n\nTuberculosis has been a scourge of humanity for millennia: the oldest known cases are in a pair of 9,000-year-old skeletons.\n\nNature. 2022. PMID: 35534687"
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html#q5-what-are-the-historical-vaccination-policies-for-the-bcg-tuberculosis-vaccine-in-various-countries",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html#q5-what-are-the-historical-vaccination-policies-for-the-bcg-tuberculosis-vaccine-in-various-countries",
    "title": "The biological-relevant questions",
    "section": "Q5: What are the historical vaccination policies for the BCG tuberculosis vaccine in various countries?",
    "text": "Q5: What are the historical vaccination policies for the BCG tuberculosis vaccine in various countries?\nA5: Visit THE BCG WORLD ATLAS.\nPLoS Med. 2011. PMID: 21445325"
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html#q6-what-are-the-differences-between-qupath-and-imagej-in-brief",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html#q6-what-are-the-differences-between-qupath-and-imagej-in-brief",
    "title": "The biological-relevant questions",
    "section": "Q6: What are the differences between QuPath and ImageJ (in brief)?",
    "text": "Q6: What are the differences between QuPath and ImageJ (in brief)?\nA6:\n\nThereâ€™s a lot that QuPath can do that ImageJ canâ€™t, especially when it comes to working with whole slide images and object classification. But it works the other way too: thereâ€™s also a lot thatâ€™s possible with ImageJ, but which isnâ€™t possible with QuPath alone.\n\n\nFortunately, you donâ€™t have to choose one or the other. They are both open and can be used together.\n\nQuPath"
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html#q7-how-do-we-know-we-can-trust-the-bioimage-analysis-results",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html#q7-how-do-we-know-we-can-trust-the-bioimage-analysis-results",
    "title": "The biological-relevant questions",
    "section": "Q7: How do we know we can trust the bioimage analysis results?",
    "text": "Q7: How do we know we can trust the bioimage analysis results?\nA7:\n\nExcellent question - stay skeptical!\n\n\nImage analysis lets you generate numbers, but these can be sensitive to how precisely you do the analysis (with or without machine learning). QuPath gives you the tools to make the measurements and to visualize them, but the meaning and validation is up to the user.\n\n\nThis is why image analysis results (from any software) should be carefully validated and treated with caution. Doing this is challenging because the â€˜truthâ€™ can be hard to define. One way is to compare with expert evaluation. Another (in some cases) is to use clinical outcome. Both these have limitations; validation is almost always hard â€“ but crucial.\n\n\nThere is also the possibility of bugs in any software. If you find any discrepancies, please report them so they can be investigated and fixed if necessary.\n\nQuPath"
  },
  {
    "objectID": "posts/To-present_bio-miscellany_Q-and-A/index.html#q8-what-is-the-relationship-between-image-analysis-objectivity",
    "href": "posts/To-present_bio-miscellany_Q-and-A/index.html#q8-what-is-the-relationship-between-image-analysis-objectivity",
    "title": "The biological-relevant questions",
    "section": "Q8: What is the relationship between image analysis & objectivity?",
    "text": "Q8: What is the relationship between image analysis & objectivity?\nA8:\n\nOne of the claimed advantages of image analysis over visual assessment is that it is objective.\n\n\nI hope this tutorials helps demonstrate why this is completely wrong!\n\n\nEven for this very simple example, we need to make decisions:\n\n\n\nAt what resolution will we perform our detection?\nWhat should be included in the tissue? Do we want areas of fat or not?\nHow to we define our stain colors?\nWhat thresholds do we use?\n\n\n\nAll of these can impact the results. Different people may (subjectively) make different decisions, and the results of their analysis will differ accordingly.\n\n\nQuPath does not answer these questions for you, but gives you the tools for you to construct your own analysis pipelines.\n\n\nHowever, while it is important to be aware that image analysis is not objective, this does not make it useless. Used cautiously â€“ and with careful validation â€“ image analysis may be faster, more reproducible, and more quantitative than visual assessment.\n\nQuPath"
  }
]